1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The STAT3 inhibitor GPB730 enhances the sensitivity to enzalutamide in prostate cancer cells
(
- Contribution to journal › Article
- 2013
-
Mark
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.
(
- Contribution to journal › Article
-
Mark
The tumour suppressor miR-34c targets MET in prostate cancer cells.
(
- Contribution to journal › Article